Immuron (IMRN) Cash & Equivalents (2015 - 2026)
Immuron (IMRN) posted Cash & Equivalents of $9.0 million for Q3 2026, up 218.59% on a QoQ basis from $2.8 million in Q4 2025, and up 31759.15% year-over-year from N/an in Q3 2025.
Powered by 
Analysis
Immuron (IMRN) Cash & Equivalents (2015 - 2026) Analysis & Trends
Immuron has reported Cash & Equivalents for 12 years, with the latest figure at $9.0 million in Q3 2026.
- On a quarterly basis, Cash & Equivalents rose 31759.15% year-over-year to $9.0 million in Q3 2026; TTM through Aug 2026 was $9.0 million, a 31759.15% increase from a year earlier, with the FY2026 full-year figure at $9.0 million, up 31759.15% from the prior year.
- Cash & Equivalents was $9.0 million for Q3 2026 at Immuron, up from $2.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $15.8 million in Q2 2022, with the low at $28305.3 in Q3 2025.
- Average Cash & Equivalents over 5 years is $7.8 million, with a median of $8.4 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Cash & Equivalents tumbled 98.88% in 2023, then jumped 31759.15% in 2026.
- Over 5 years, Cash & Equivalents stood at $14.5 million in 2022, then slipped by 23.1% to $11.2 million in 2023, then sank by 31.76% to $7.6 million in 2024, then slumped by 62.87% to $2.8 million in 2025, then soared by 218.59% to $9.0 million in 2026.
- The last three Cash & Equivalents figures came in at $9.0 million (Q3 2026), $2.8 million (Q4 2025), and $28305.3 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | 1.72 Bn |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | 3.58 Bn |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | 1.25 Bn |
| 10 | Immuron | 7.25 Mn | -1.77 Mn | - | 9.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 9.02 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 2, 2025 | 28,305.26 |
| Jun 30, 2025 | 1.81 Mn |
| Dec 31, 2024 | 7.62 Mn |
| Sep 9, 2024 | 77,676.77 |
| Jun 30, 2024 | 7.68 Mn |
| Dec 31, 2023 | 11.17 Mn |
| Sep 28, 2023 | 11.25 Mn |
| Aug 30, 2023 | 171,597.64 |
| Jun 30, 2023 | 11.47 Mn |
| Dec 31, 2022 | 14.53 Mn |
| Aug 31, 2022 | 15.38 Mn |
| Jun 30, 2022 | 15.84 Mn |
| Dec 31, 2021 | 18.34 Mn |
| Sep 30, 2021 | 18.42 Mn |
| Jun 30, 2021 | 19.29 Mn |
| Dec 31, 2020 | 2.38 Mn |
| Sep 1, 2020 | 3.25 Mn |
| Jun 30, 2020 | 2.13 Mn |
API Access
Immuron Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();